An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Community-Acquired Pneumonia

Po Chuan Chen, Wen I. Liao, Ying Chuan Wang, Wei Chou Chang, Chin-Wung Hsu, Ying Hsin Chen, Shih Hung Tsai

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Several studies argue against the association between admission hyperglycemia and adverse outcomes in infected diabetic patients. When investigating the association, it is necessary to consider preexisting hyperglycemia. The objective of this study was to assess whether stress-induced hyperglycemia, determined by the glycemic gap between admission glucose levels and A1c-derived average glucose levels adversely affects outcomes in diabetic patients admitted to hospital with community-acquired pneumonia (CAP). We retrospectively analyzed the glycemic gap and adverse outcomes of diabetic patients hospitalized because of CAP from June 1, 2007 to August 31, 2012 in single medical center in Taiwan. A total of 203 patients admitted with principal diagnosis of CAP and available data of glycemic gap. Patients with glycemic gaps ≥40mg/dL had greater AUROC values for the development of adverse outcomes compared with acute hyperglycemia and long-term glycemic controls. Patients with an elevated glycemic gap had an odds ratio of 3.84 for the incidence of combined adverse outcomes. Incorporation of the glycemic gap into pneumonia severity index, CURB-65 or SMART-COP scores, increased the discriminative performance of predicting the development of adverse outcomes. Glycemic gaps were associated with adverse outcomes of diabetic CAP patients. The discriminative performance of the calculated glycemic gaps was comparable with those of current clinical scoring systems and may further increase the AUROC of each system.

Original languageEnglish
Pages (from-to)e1456
JournalMedicine (United States)
Volume94
Issue number34
DOIs
Publication statusPublished - Aug 1 2015
Externally publishedYes

Fingerprint

Pneumonia
Hyperglycemia
Glucose
Taiwan
Odds Ratio
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Community-Acquired Pneumonia. / Chen, Po Chuan; Liao, Wen I.; Wang, Ying Chuan; Chang, Wei Chou; Hsu, Chin-Wung; Chen, Ying Hsin; Tsai, Shih Hung.

In: Medicine (United States), Vol. 94, No. 34, 01.08.2015, p. e1456.

Research output: Contribution to journalArticle

Chen, Po Chuan ; Liao, Wen I. ; Wang, Ying Chuan ; Chang, Wei Chou ; Hsu, Chin-Wung ; Chen, Ying Hsin ; Tsai, Shih Hung. / An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Community-Acquired Pneumonia. In: Medicine (United States). 2015 ; Vol. 94, No. 34. pp. e1456.
@article{8a8213ef772c40e485e8691728dc8169,
title = "An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Community-Acquired Pneumonia",
abstract = "Several studies argue against the association between admission hyperglycemia and adverse outcomes in infected diabetic patients. When investigating the association, it is necessary to consider preexisting hyperglycemia. The objective of this study was to assess whether stress-induced hyperglycemia, determined by the glycemic gap between admission glucose levels and A1c-derived average glucose levels adversely affects outcomes in diabetic patients admitted to hospital with community-acquired pneumonia (CAP). We retrospectively analyzed the glycemic gap and adverse outcomes of diabetic patients hospitalized because of CAP from June 1, 2007 to August 31, 2012 in single medical center in Taiwan. A total of 203 patients admitted with principal diagnosis of CAP and available data of glycemic gap. Patients with glycemic gaps ≥40mg/dL had greater AUROC values for the development of adverse outcomes compared with acute hyperglycemia and long-term glycemic controls. Patients with an elevated glycemic gap had an odds ratio of 3.84 for the incidence of combined adverse outcomes. Incorporation of the glycemic gap into pneumonia severity index, CURB-65 or SMART-COP scores, increased the discriminative performance of predicting the development of adverse outcomes. Glycemic gaps were associated with adverse outcomes of diabetic CAP patients. The discriminative performance of the calculated glycemic gaps was comparable with those of current clinical scoring systems and may further increase the AUROC of each system.",
author = "Chen, {Po Chuan} and Liao, {Wen I.} and Wang, {Ying Chuan} and Chang, {Wei Chou} and Chin-Wung Hsu and Chen, {Ying Hsin} and Tsai, {Shih Hung}",
year = "2015",
month = "8",
day = "1",
doi = "10.1097/MD.0000000000001456",
language = "English",
volume = "94",
pages = "e1456",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "34",

}

TY - JOUR

T1 - An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Community-Acquired Pneumonia

AU - Chen, Po Chuan

AU - Liao, Wen I.

AU - Wang, Ying Chuan

AU - Chang, Wei Chou

AU - Hsu, Chin-Wung

AU - Chen, Ying Hsin

AU - Tsai, Shih Hung

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Several studies argue against the association between admission hyperglycemia and adverse outcomes in infected diabetic patients. When investigating the association, it is necessary to consider preexisting hyperglycemia. The objective of this study was to assess whether stress-induced hyperglycemia, determined by the glycemic gap between admission glucose levels and A1c-derived average glucose levels adversely affects outcomes in diabetic patients admitted to hospital with community-acquired pneumonia (CAP). We retrospectively analyzed the glycemic gap and adverse outcomes of diabetic patients hospitalized because of CAP from June 1, 2007 to August 31, 2012 in single medical center in Taiwan. A total of 203 patients admitted with principal diagnosis of CAP and available data of glycemic gap. Patients with glycemic gaps ≥40mg/dL had greater AUROC values for the development of adverse outcomes compared with acute hyperglycemia and long-term glycemic controls. Patients with an elevated glycemic gap had an odds ratio of 3.84 for the incidence of combined adverse outcomes. Incorporation of the glycemic gap into pneumonia severity index, CURB-65 or SMART-COP scores, increased the discriminative performance of predicting the development of adverse outcomes. Glycemic gaps were associated with adverse outcomes of diabetic CAP patients. The discriminative performance of the calculated glycemic gaps was comparable with those of current clinical scoring systems and may further increase the AUROC of each system.

AB - Several studies argue against the association between admission hyperglycemia and adverse outcomes in infected diabetic patients. When investigating the association, it is necessary to consider preexisting hyperglycemia. The objective of this study was to assess whether stress-induced hyperglycemia, determined by the glycemic gap between admission glucose levels and A1c-derived average glucose levels adversely affects outcomes in diabetic patients admitted to hospital with community-acquired pneumonia (CAP). We retrospectively analyzed the glycemic gap and adverse outcomes of diabetic patients hospitalized because of CAP from June 1, 2007 to August 31, 2012 in single medical center in Taiwan. A total of 203 patients admitted with principal diagnosis of CAP and available data of glycemic gap. Patients with glycemic gaps ≥40mg/dL had greater AUROC values for the development of adverse outcomes compared with acute hyperglycemia and long-term glycemic controls. Patients with an elevated glycemic gap had an odds ratio of 3.84 for the incidence of combined adverse outcomes. Incorporation of the glycemic gap into pneumonia severity index, CURB-65 or SMART-COP scores, increased the discriminative performance of predicting the development of adverse outcomes. Glycemic gaps were associated with adverse outcomes of diabetic CAP patients. The discriminative performance of the calculated glycemic gaps was comparable with those of current clinical scoring systems and may further increase the AUROC of each system.

UR - http://www.scopus.com/inward/record.url?scp=84944902853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944902853&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000001456

DO - 10.1097/MD.0000000000001456

M3 - Article

C2 - 26313809

AN - SCOPUS:84944902853

VL - 94

SP - e1456

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 34

ER -